Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Comparison of multiple sclerosis patients with and without oligoclonal IgG bands in South China.

Lu T, Zhao L, Sun X, Au C, Huang Y, Yang Y, Bao J, Wu A, Kermode AG, Qiu W, Lau AY.

J Clin Neurosci. 2019 Aug;66:51-55. doi: 10.1016/j.jocn.2019.05.025. Epub 2019 May 30.

PMID:
31155343
2.

Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome.

Trend S, Jones AP, Cha L, Cooper MN, Geldenhuys S, Fabis-Pedrini MJ, Carroll WM, Cole JM, Booth DR, Lucas RM, French MA, Byrne SN, Kermode AG, Hart PH.

Sci Rep. 2019 May 28;9(1):7980. doi: 10.1038/s41598-019-44488-6.

3.

Seizure and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis in a Retrospective Cohort of Chinese Patients.

Zhong X, Zhou Y, Chang Y, Wang J, Shu Y, Sun X, Peng L, Lau AY, Kermode AG, Qiu W.

Front Neurol. 2019 Apr 26;10:415. doi: 10.3389/fneur.2019.00415. eCollection 2019.

4.

Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome.

Zhong X, Chang Y, Tan S, Wang J, Sun X, Wu A, Peng L, Lau AY, Kermode AG, Qiu W.

BMC Neurol. 2019 May 9;19(1):94. doi: 10.1186/s12883-019-1324-4.

5.

Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinct from Astrocytopathy Induced by AQP4-IgG.

Fang L, Kang X, Wang Z, Wang S, Wang J, Zhou Y, Chen C, Sun X, Yan Y, Kermode AG, Peng L, Qiu W.

Neurosci Bull. 2019 Apr 30. doi: 10.1007/s12264-019-00375-8. [Epub ahead of print]

PMID:
31041694
6.

Harding's disease: an important MS mimic.

Joshi S, Kermode AG.

BMJ Case Rep. 2019 Mar 31;12(3). pii: e228337. doi: 10.1136/bcr-2018-228337.

PMID:
30936345
7.

Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor.

Shu Y, Long Y, Wang S, Hu W, Zhou J, Xu H, Chen C, Ou Y, Lu Z, Lau AY, Yu X, Kermode AG, Qiu W.

Ann Clin Transl Neurol. 2019 Jan 8;6(2):392-396. doi: 10.1002/acn3.712. eCollection 2019 Feb.

8.

Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder.

Zhou Y, Zhong X, Shu Y, Cui C, Wang J, Wang Y, Li X, Chen Z, Peng L, Kermode A, Qiu W.

Mult Scler Relat Disord. 2019 Feb;28:213-220. doi: 10.1016/j.msard.2018.12.038. Epub 2019 Jan 3.

PMID:
30623860
9.

Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.

Thomas R, Kermode AR.

Mol Genet Metab. 2019 Feb;126(2):83-97. doi: 10.1016/j.ymgme.2018.11.011. Epub 2018 Nov 22. Review.

PMID:
30528228
10.

Warts and all: Fingolimod and unusual HPV-associated lesions.

Triplett J, Kermode AG, Corbett A, Reddel SW.

Mult Scler. 2018 Nov 14:1352458518807088. doi: 10.1177/1352458518807088. [Epub ahead of print]

PMID:
30427266
11.

New Irreversible α-l-Iduronidase Inhibitors and Activity-Based Probes.

Artola M, Kuo CL, McMahon SA, Oehler V, Hansen T, van der Lienden M, He X, van den Elst H, Florea BI, Kermode AR, van der Marel GA, Gloster TM, Codée JDC, Overkleeft HS, Aerts JMFG.

Chemistry. 2018 Dec 17;24(71):19081-19088. doi: 10.1002/chem.201804662. Epub 2018 Nov 26.

12.

Vitamin D C3-epimer levels are proportionally higher with oral vitamin D supplementation compared to ultraviolet irradiation of skin in mice but not humans.

Ghaly S, Bliuc D, Center JR, Clarke MW, Jones AP, Trend S, Kermode AG, Neale RE, Hart PH.

J Steroid Biochem Mol Biol. 2019 Feb;186:110-116. doi: 10.1016/j.jsbmb.2018.10.002. Epub 2018 Oct 5.

PMID:
30296587
13.

Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.

Fabis-Pedrini MJ, Bundell C, Wee CK, Lucas M, McLean-Tooke A, Mastaglia FL, Carroll WM, Kermode AG.

J Neuroimmunol. 2018 Nov 15;324:76-80. doi: 10.1016/j.jneuroim.2018.09.006. Epub 2018 Sep 14.

PMID:
30248527
14.

Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes.

Zhou Y, Jia X, Yang H, Chen C, Sun X, Peng L, Kermode AG, Qiu W.

Eur J Neurol. 2019 Jan;26(1):175-183. doi: 10.1111/ene.13791. Epub 2018 Oct 15.

PMID:
30153357
15.

Tryptophan and arginine catabolic enzymes and regulatory cytokines in clinically isolated syndrome and multiple sclerosis.

Cha L, Jones AP, Trend S, Byrne SN, Fabis-Pedrini MJ, Carroll WM, Lucas RM, Cole JM, Booth DR, Kermode AG, Hart PH.

Clin Transl Immunology. 2018 Aug 16;7(8):e1037. doi: 10.1002/cti2.1037. eCollection 2018.

16.

Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome.

Trend S, Jones AP, Cha L, Byrne SN, Geldenhuys S, Fabis-Pedrini MJ, Carroll WM, Cole JM, Booth DR, Lucas RM, Kermode AG, French MA, Hart PH.

Front Immunol. 2018 Jul 13;9:1590. doi: 10.3389/fimmu.2018.01590. eCollection 2018.

17.

Dimethyl fumarate-associated transient bone marrow oedema syndrome.

Triplett J, Vijayan S, Prince R, Kermode A.

Mult Scler. 2019 May;25(6):876-879. doi: 10.1177/1352458518791132. Epub 2018 Jul 27.

PMID:
30051766
18.

High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis.

Lau A, Qiu W, Kermode A, Au C, Ng A, Wong A, Ma SH, Au L, Ma K, Ip B, Mok V.

Mult Scler J Exp Transl Clin. 2018 Jul 17;4(3):2055217318788699. doi: 10.1177/2055217318788699. eCollection 2018 Jul-Sep.

19.

Brain Immunohistopathology in a Patient with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy.

Shu Y, Long Y, Chang Y, Li R, Sun X, Wang Y, Huang Y, Li J, Chen J, Yang Y, Lu Z, Hu X, Kermode AG, Qiu W.

Neuroimmunomodulation. 2018;25(1):1-6. doi: 10.1159/000488879. Epub 2018 May 22.

PMID:
29788018
20.

A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study.

Hart PH, Jones AP, Trend S, Cha L, Fabis-Pedrini MJ, Cooper MN, d'Este C, Geldenhuys S, Carroll WM, Byrne SN, Booth DR, Cole JM, Lucas RM, Kermode AG.

Mult Scler J Exp Transl Clin. 2018 Apr 27;4(2):2055217318773112. doi: 10.1177/2055217318773112. eCollection 2018 Apr-Jun.

21.

Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort.

Fabis-Pedrini MJ, James I, Seewann A, Yau WY, van de Bovenkamp AA, Sanders FRK, Qiu W, Burton J, Mastaglia FL, Carroll WM, Kermode AG.

J Neurol Sci. 2018 May 15;388:12-18. doi: 10.1016/j.jns.2018.02.036. Epub 2018 Feb 22.

PMID:
29627005
22.

B cell depleting therapy for multiple sclerosis overlapping with neuromyelitis optica spectrum disorder.

Lu T, Shu Y, Dai Y, Liu X, Chang Y, Huang Q, Kermode AG, Qiu W.

Mult Scler Relat Disord. 2018 May;22:83-85. doi: 10.1016/j.msard.2018.03.017. Epub 2018 Mar 26.

PMID:
29621743
23.

Association of serum Cystatin C with neuromyelitis optica spectrum disorders.

Shu Y, Zhang L, Chang Y, Li R, Sun X, Li J, Wu H, Yang Y, Peng L, Lu Z, Kermode AG, Qiu W.

Eur J Neurol. 2018 Jul;25(7):999-1002. doi: 10.1111/ene.13646. Epub 2018 May 4.

PMID:
29603501
24.

Study of the placentae of patients with neuromyelitis optica spectrum disorder.

Chang Y, Shu Y, Sun X, Lu T, Chen C, Fang L, He D, Xu C, Lu Z, Hu X, Peng L, Kermode AG, Qiu W.

J Neurol Sci. 2018 Apr 15;387:119-123. doi: 10.1016/j.jns.2018.01.040. Epub 2018 Feb 2.

PMID:
29571847
25.

Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients.

Li R, Sun X, Shu Y, Wang Y, Xiao L, Wang Z, Hu X, Kermode AG, Qiu W.

J Neuroimmunol. 2017 Dec 15;313:56-60. doi: 10.1016/j.jneuroim.2017.10.013. Epub 2017 Oct 19.

PMID:
29153609
26.

Ectrodactyly in a Chinese patient born to a mother with neuromyelitis optica spectrum disorder.

Chang Y, Shu Y, Sun X, Xu C, He D, Fang L, Chen C, Hu X, Kermode A, Qiu W.

Mult Scler Relat Disord. 2018 Jan;19:70-72. doi: 10.1016/j.msard.2017.11.009. Epub 2017 Nov 8.

PMID:
29149698
27.

N-glycan structures and downstream mannose-phosphorylation of plant recombinant human alpha-L-iduronidase: toward development of enzyme replacement therapy for mucopolysaccharidosis I.

Pierce OM, McNair GR, He X, Kajiura H, Fujiyama K, Kermode AR.

Plant Mol Biol. 2017 Dec;95(6):593-606. doi: 10.1007/s11103-017-0673-x. Epub 2017 Nov 8.

PMID:
29119347
28.

Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis.

Shu Y, Li R, Qiu W, Chang Y, Sun X, Fang L, Chen C, Yang Y, Lu Z, Hu X, Kermode AG.

Mult Scler Relat Disord. 2017 Nov;18:65-70. doi: 10.1016/j.msard.2017.09.021. Epub 2017 Sep 20.

PMID:
29107207
29.

Infections in neuromyelitis optica spectrum disorder.

Zhong X, Zhou Y, Lu T, Wang Z, Fang L, Peng L, Kermode AG, Qiu W.

J Clin Neurosci. 2018 Jan;47:14-19. doi: 10.1016/j.jocn.2017.10.005. Epub 2017 Oct 21. Review.

PMID:
29066232
30.

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

Kalincik T, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Lechner-Scott J, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Solaro C, Grand'Maison F, Hupperts R, Prevost J, Sola P, Ferraro D, Terzi M, Butler E, Slee M, Kermode A, Fabis-Pedrini M, McCombe P, Barnett M, Shaw C, Hodgkinson S, Butzkueven H; MSBase Study Group.

Mult Scler. 2018 Oct;24(12):1617-1626. doi: 10.1177/1352458517728812. Epub 2017 Aug 31. Erratum in: Mult Scler. 2017 Dec;23(14):NP1.

PMID:
28857680
31.

Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis.

Jones AP, Trend S, Byrne SN, Fabis-Pedrini MJ, Geldenhuys S, Nolan D, Booth DR, Carroll WM, Lucas RM, Kermode AG, Hart PH.

Clin Transl Immunology. 2017 May 26;6(5):e143. doi: 10.1038/cti.2017.18. eCollection 2017 May.

32.

Evolving Identification of Blood Cells Associated with Clinically Isolated Syndrome: Importance of Time since Clinical Presentation and Diagnostic MRI.

Trend S, Jones AP, Geldenhuys S, Byrne SN, Fabis-Pedrini MJ, Nolan D, Booth DR, Carroll WM, Lucas RM, Kermode AG, Hart PH.

Int J Mol Sci. 2017 Jun 15;18(6). pii: E1277. doi: 10.3390/ijms18061277.

33.

Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS.

Cull G, Hall D, Fabis-Pedrini MJ, Carroll WM, Forster L, Robins F, Ghassemifar R, Crosbie C, Walters S, James I, Augustson B, Kermode AK.

Mult Scler J Exp Transl Clin. 2017 Mar 23;3(1):2055217317700167. doi: 10.1177/2055217317700167. eCollection 2017 Jan-Mar.

34.

Fabry heterozygote mimicking multiple sclerosis.

Yau WY, Fabis-Pedrini MJ, Kermode AG.

BMJ Case Rep. 2017 Jun 2;2017. pii: bcr-2017-220274. doi: 10.1136/bcr-2017-220274.

35.

Incidence and prevalence of NMOSD in Australia and New Zealand.

Bukhari W, Prain KM, Waters P, Woodhall M, O'Gorman CM, Clarke L, Silvestrini RA, Bundell CS, Abernethy D, Bhuta S, Blum S, Boggild M, Boundy K, Brew BJ, Brown M, Brownlee WJ, Butzkueven H, Carroll WM, Chen C, Coulthard A, Dale RC, Das C, Dear K, Fabis-Pedrini MJ, Fulcher D, Gillis D, Hawke S, Heard R, Henderson APD, Heshmat S, Hodgkinson S, Jimenez-Sanchez S, Killpatrick T, King J, Kneebone C, Kornberg AJ, Lechner-Scott J, Lin MW, Lynch C, Macdonell R, Mason DF, McCombe PA, Pender MP, Pereira JA, Pollard JD, Reddel SW, Shaw C, Spies J, Stankovich J, Sutton I, Vucic S, Walsh M, Wong RC, Yiu EM, Barnett MH, Kermode AG, Marriott MP, Parratt JDE, Slee M, Taylor BV, Willoughby E, Wilson RJ, Vincent A, Broadley SA.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):632-638. doi: 10.1136/jnnp-2016-314839. Epub 2017 May 26.

36.

AtPME3, a ubiquitous cell wall pectin methylesterase of Arabidopsis thaliana, alters the metabolism of cruciferin seed storage proteins during post-germinative growth of seedlings.

Guénin S, Hardouin J, Paynel F, Müller K, Mongelard G, Driouich A, Lerouge P, Kermode AR, Lehner A, Mollet JC, Pelloux J, Gutierrez L, Mareck A.

J Exp Bot. 2017 Feb 1;68(5):1083-1095. doi: 10.1093/jxb/erx023.

PMID:
28375469
37.

Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis.

Fewings N, Gatt PN, McKay FC, Parnell GP, Schibeci SD, Edwards J, Basuki MA, Goldinger A, Fabis-Pedrini MJ, Kermode AG, Manrique CP, McCauley JL, Nickles D, Baranzini SE, Burke T, Vucic S, Stewart GJ, Booth DR.

Data Brief. 2017 Feb 21;11:364-370. doi: 10.1016/j.dib.2017.02.040. eCollection 2017 Apr.

38.

Narrowband UVB Phototherapy for Clinically Isolated Syndrome: A Trial to Deliver the Benefits of Vitamin D and Other UVB-Induced Molecules.

Hart PH, Lucas RM, Booth DR, Carroll WM, Nolan D, Cole JM, Jones AP, Kermode AG.

Front Immunol. 2017 Jan 24;8:3. doi: 10.3389/fimmu.2017.00003. eCollection 2017.

39.

Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG.

Zhou Y, Huang Q, Lu T, Sun X, Fang L, Lu Z, Hu X, Kermode A, Qiu W.

J Clin Neurosci. 2017 Apr;38:71-73. doi: 10.1016/j.jocn.2016.12.022. Epub 2017 Jan 19.

PMID:
28111033
40.

The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis.

Fewings NL, Gatt PN, McKay FC, Parnell GP, Schibeci SD, Edwards J, Basuki MA, Goldinger A, Fabis-Pedrini MJ, Kermode AG, Manrique CP, McCauley JL, Nickles D, Baranzini SE, Burke T, Vucic S, Stewart GJ, Booth DR.

J Autoimmun. 2017 Mar;78:57-69. doi: 10.1016/j.jaut.2016.12.006. Epub 2017 Jan 4.

PMID:
28063629
41.

Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China.

Huang Y, Wang Y, Zhou Y, Huang Q, Sun X, Chen C, Fang L, Long Y, Yang H, Wang H, Li C, Lu Z, Hu X, Kermode AG, Qiu W.

J Neurol Sci. 2017 Jan 15;372:152-156. doi: 10.1016/j.jns.2016.11.054. Epub 2016 Nov 23.

PMID:
28017203
42.

Circulating immune cells in multiple sclerosis.

Jones AP, Kermode AG, Lucas RM, Carroll WM, Nolan D, Hart PH.

Clin Exp Immunol. 2017 Feb;187(2):193-203. doi: 10.1111/cei.12878. Epub 2016 Nov 2. Review.

43.

CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags.

Joshi S, Yau W, Kermode A.

J Clin Neurosci. 2017 Jan;35:75-77. doi: 10.1016/j.jocn.2016.09.025. Epub 2016 Oct 20.

PMID:
27773545
44.

Acute reversible seronegative cerebellar ataxia in a young woman with ovarian teratoma.

Yau WY, Fabis-Pedrini MJ, Kermode AG.

J Neurol Sci. 2016 Oct 15;369:227-228. doi: 10.1016/j.jns.2016.08.033. Epub 2016 Aug 16. No abstract available.

PMID:
27653894
45.

Contribution of different relapse phenotypes to disability in multiple sclerosis.

Stewart T, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, Duquette P, Girard M, Prat A, Lugaresi A, Grand'Maison F, Grammond P, Sola P, Shaygannejad V, Hupperts R, Alroughani R, Oreja-Guevara C, Pucci E, Boz C, Lechner-Scott J, Bergamaschi R, Van Pesch V, Iuliano G, Ramo C, Taylor B, Slee M, Spitaleri D, Granella F, Verheul F, McCombe P, Hodgkinson S, Amato MP, Vucic S, Gray O, Cristiano E, Barnett M, Sanchez Menoyo JL, van Munster E, Saladino ML, Olascoaga J, Prevost J, Deri N, Shaw C, Singhal B, Moore F, Rozsa C, Shuey N, Skibina O, Kister I, Petkovska-Boskova T, Ampapa R, Kermode A, Butzkueven H, Jokubaitis V, Kalincik T; MSBase Study Group.

Mult Scler. 2017 Feb;23(2):266-276. doi: 10.1177/1352458516643392. Epub 2016 Jul 11.

PMID:
27055805
46.

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.

Mahurkar S, Moldovan M, Suppiah V, Sorosina M, Clarelli F, Liberatore G, Malhotra S, Montalban X, Antigüedad A, Krupa M, Jokubaitis VG, McKay FC, Gatt PN, Fabis-Pedrini MJ, Martinelli V, Comi G, Lechner-Scott J, Kermode AG, Slee M, Taylor BV, Vandenbroeck K, Comabella M, Boneschi FM; Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), King C.

Pharmacogenomics J. 2017 Jul;17(4):312-318. doi: 10.1038/tpj.2016.20. Epub 2016 Mar 22.

PMID:
27001119
47.

The U.S. Culture Collection Network Lays the Foundation for Progress in Preservation of Valuable Microbial Resources.

McCluskey K, Alvarez A, Bennett R, Bokati D, Boundy-Mills K, Brown D, Bull CT, Coffey M, Dreaden T, Duke C, Dye G, Ehmke E, Eversole K, Fenstermacher K, Geiser D, Glaeser JA, Greene S, Gribble L, Griffith MP, Hanser K, Humber R, Johnson BW, Kermode A, Krichevsky M, Laudon M, Leach J, Leslie J, May M, Melcher U, Nobles D, Fonseca NR, Robinson S, Ryan M, Scott J, Silflow C, Vidaver A, Webb KM, Wertz JE, Yentsch S, Zehr S.

Phytopathology. 2016 Jun;106(6):532-40. doi: 10.1094/PHYTO-02-16-0074-RVW. Epub 2016 May 6.

48.

Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.

Tschochner M, Leary S, Cooper D, Strautins K, Chopra A, Clark H, Choo L, Dunn D, James I, Carroll WM, Kermode AG, Nolan D.

PLoS One. 2016 Feb 5;11(2):e0147567. doi: 10.1371/journal.pone.0147567. eCollection 2016.

49.

The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.

McKay FC, Gatt PN, Fewings N, Parnell GP, Schibeci SD, Basuki MA, Powell JE, Goldinger A, Fabis-Pedrini MJ, Kermode AG, Burke T, Vucic S, Stewart GJ, Booth DR.

Clin Immunol. 2016 Feb;163:96-107. doi: 10.1016/j.clim.2015.12.015. Epub 2016 Jan 4.

PMID:
26762769
50.

Rapid exacerbation of neuromyelitis optica after rituximab treatment.

Dai Y, Lu T, Wang Y, Fang L, Li R, Kermode AG, Qiu W.

J Clin Neurosci. 2016 Apr;26:168-70. doi: 10.1016/j.jocn.2015.08.033. Epub 2015 Dec 15.

PMID:
26704780

Supplemental Content

Loading ...
Support Center